Cases & Deals

  • Home
  • Practices
  • Pfizer acquires Angiosyn, a biopharmaceutical company

Share

Pfizer acquires Angiosyn, a biopharmaceutical company

December 2005

Client(s) Pfizer, Inc.

Jones Day acted as principal outside tax counsel to Pfizer in its agreed acquisition of Angiosyn, a biopharmaceutical company focused on the discovery and development of technology to ward off blindness.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.